Arne Sorenson will step back from his role as president and CEO at Marriott International temporarily as he undergoes further treatment for pancreatic cancer.
Sorenson has been undergoing treatment since he was diagnosed in May 2019.
“Since my diagnosis, I’ve been working with a great medical team at Johns Hopkins to treat this cancer,” Sorenson said.
“While I have worked throughout my treatment to date and plan to remain as engaged in the business as my health allows, the right thing to do for me, my family and the company is to focus on my health.”
Sorenson is expected to step away for several months, but “will stay involved in directing the company”, according to a media release.
In the interim, Stephanie Linnartz, Group President, Consumer Operations, Technology and Emerging Businesses, will oversee the company’s international lodging division, as well as Legal, Human Resources and Communications & Public Affairs.
Tony Capuano, Group President, Global Development, Design and Operations Services, will oversee the company’s US and Canada lodging division and Finance.
“I know Stephanie and Tony will work with Marriott’s strong executive team to continue to move the company forward,” said Sorenson.
“I, along with my family and my medical team, remain optimistic about my prognosis and I plan to return full-time after the conclusion of my treatments.”